CD19 Positive
Also known as: CD19-positive
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00531 | Cyclophosphamide | 1 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 3 |
DB01073 | Fludarabine | 1 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 | Completed | 1 |
DB01073 | Fludarabine | 1 | Recruiting | 3 |
DB13881 | Tisagenlecleucel | 1 | Completed | 1 |
DB06273 | Tocilizumab | 1 | Recruiting | 1 |
DB02379 | Beta-D-Glucose | 1 / 2 | Withdrawn | 1 |
DB09052 | Blinatumomab | 1 / 2 | Recruiting | 1 |
DB00262 | Carmustine | 1 / 2 | Withdrawn | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Withdrawn | 1 |
DB00987 | Cytarabine | 1 / 2 | Withdrawn | 1 |
DB00773 | Etoposide | 1 / 2 | Withdrawn | 1 |
DB00099 | Filgrastim | 1 / 2 | Withdrawn | 1 |
DB01073 | Fludarabine | 1 / 2 | Withdrawn | 1 |
DB00888 | Mechlorethamine | 1 / 2 | Withdrawn | 1 |
DB00075 | Muromonab | 1 / 2 | Recruiting | 1 |
DB15721 | Natural Killer Cell | 1 / 2 | Withdrawn | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB00073 | Rituximab | 1 / 2 | Withdrawn | 1 |